DekaBank Deutsche Girozentrale’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-76,900
| Closed | -$127K | – | 1321 |
|
2023
Q1 | $127K | Hold |
76,900
| – | – | ﹤0.01% | 1232 |
|
2022
Q4 | $226K | Hold |
76,900
| – | – | ﹤0.01% | 1204 |
|
2022
Q3 | $369K | Hold |
76,900
| – | – | ﹤0.01% | 1101 |
|
2022
Q2 | $306K | Hold |
76,900
| – | – | ﹤0.01% | 1118 |
|
2022
Q1 | $456K | Buy |
76,900
+7,000
| +10% | +$41.5K | ﹤0.01% | 1076 |
|
2021
Q4 | $548K | Buy |
69,900
+2,000
| +3% | +$15.7K | ﹤0.01% | 1078 |
|
2021
Q3 | $618K | Hold |
67,900
| – | – | ﹤0.01% | 1004 |
|
2021
Q2 | $786K | Hold |
67,900
| – | – | ﹤0.01% | 966 |
|
2021
Q1 | $786K | Hold |
67,900
| – | – | ﹤0.01% | 952 |
|
2020
Q4 | $1.19M | Sell |
67,900
-3,400
| -5% | -$59.4K | ﹤0.01% | 815 |
|
2020
Q3 | $695K | Buy |
+71,300
| New | +$695K | ﹤0.01% | 857 |
|
2019
Q4 | – | Sell |
-73,700
| Closed | -$677K | – | 1212 |
|
2019
Q3 | $677K | Sell |
73,700
-78,700
| -52% | -$723K | ﹤0.01% | 730 |
|
2019
Q2 | $1.61M | Buy |
152,400
+95,700
| +169% | +$1.01M | 0.01% | 682 |
|
2019
Q1 | $1.03M | Buy |
56,700
+10,500
| +23% | +$191K | 0.01% | 755 |
|
2018
Q4 | $489K | Sell |
46,200
-10,500
| -19% | -$111K | ﹤0.01% | 836 |
|
2018
Q3 | $1.03M | Sell |
56,700
-1,500
| -3% | -$27.2K | 0.01% | 769 |
|
2018
Q2 | $809K | Buy |
58,200
+20,000
| +52% | +$278K | 0.01% | 798 |
|
2018
Q1 | $753K | Buy |
+38,200
| New | +$753K | 0.01% | 788 |
|
2016
Q2 | – | Sell |
-36,500
| Closed | -$210K | – | 1037 |
|
2016
Q1 | $210K | Buy |
36,500
+800
| +2% | +$4.6K | ﹤0.01% | 843 |
|
2015
Q4 | $336K | Buy |
35,700
+500
| +1% | +$4.71K | ﹤0.01% | 773 |
|
2015
Q3 | $199K | Buy |
35,200
+1,500
| +4% | +$8.48K | ﹤0.01% | 871 |
|
2015
Q2 | $374K | Buy |
33,700
+1,300
| +4% | +$14.4K | ﹤0.01% | 762 |
|
2015
Q1 | $508K | Sell |
32,400
-4,100
| -11% | -$64.3K | 0.01% | 709 |
|
2014
Q4 | $541K | Sell |
36,500
-3,500
| -9% | -$51.9K | 0.01% | 674 |
|
2014
Q3 | $431K | Buy |
40,000
+1,000
| +3% | +$10.8K | 0.01% | 688 |
|
2014
Q2 | $596K | Buy |
39,000
+1,900
| +5% | +$29K | 0.01% | 576 |
|
2014
Q1 | $671K | Buy |
37,100
+2,800
| +8% | +$50.6K | 0.01% | 532 |
|
2013
Q4 | $483K | Buy |
34,300
+4,500
| +15% | +$63.4K | 0.01% | 552 |
|
2013
Q3 | $313K | Buy |
+29,800
| New | +$313K | 0.01% | 596 |
|